Despite favorable state-wide election results, concerns among cannabis investors have increased and cannabis stocks continue to move lower following an overextended industry wide rally as well as highly questionable cabinet nominations by president elect Donald Trump.
Although the recent downward trend is concerning, this weakness has created an opportunity for investors to purchase high quality cannabis investments at a considerable discount.
The Society for Neuroscience Annual Meeting was held last month in San Diego. More than 30,000 neuroscientists were in attendance. They featured talks and presentations from scientists across the research spectrum. This is the largest source of contemporary brain research in the world today.
Do we really think that modern pharmaceutical ingredients will be grown in massive grow-ops, subject to mold, fungus and pesticides? Considering other modern Bio-pharm technologies exists why farm plants? Solving ingredient supply, will become increasingly more problematic for Cannabis Pharmaceuticals companies as they move from the research lab to the pharmacy.
